Indication

Erysipelas

Erysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics. Read more about Erysipelas

25 drugs 21 manufacturers

Advertisement

Drugs that treat it

Common Erysipelas therapies.

Showing 1–9 of 25 drugs

Filter & compare in the drug finder →Opens the drug finder with Erysipelas preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Erysipelas.

Erysipelas is an acute superficial bacterial infection of the skin that primarily involves the upper dermis and extends into the superficial cutaneous lymphatics.

It can occur in both pediatric and adult populations, most frequently presenting on the lower extremities and the face following a break in the cutaneous barrier.

Pathophysiologically, it is most often caused by beta-hemolytic streptococci, particularly group A *Streptococcus* (*Streptococcus pyogenes*).

The condition is clinically distinguished by a rapid onset of intense warmth, edema, and a bright red, indurated plaque characterized by sharply demarcated, raised borders, often accompanied by systemic features such as acute fever, chills, and regional lymphadenopathy.

Personalize your experience

Follow Erysipelas and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it